Cargando…

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment

Detalles Bibliográficos
Autores principales:	Serraino, Cristina, Melchio, Remo, Badinella Martini, Marco, Gerbaudo, Laura, Fenoglio, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Ce - Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744016/ https://www.ncbi.nlm.nih.gov/pubmed/35006536 http://dx.doi.org/10.1007/s11739-021-02907-5

Ejemplares similares

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
por: Ferrara, Pietro, et al.
Publicado: (2022)

Fever During Anti-integrin Therapy: New Immunodeficiency
por: Bonfanti, Eleonora, et al.
Publicado: (2020)

The Italian NHS in Lombardy and Veneto: near but far
por: Garattini, Livio, et al.
Publicado: (2021)

Pharmaceutical patenting in the European Union: reform or riddance
por: Garattini, Livio, et al.
Publicado: (2021)

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up
por: Ponticelli, Domenico, et al.
Publicado: (2021)

Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
por: Cocomazzi, Giovanna, et al.
Publicado: (2021)

Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment
por: Bandera, Alessandra, et al.
Publicado: (2021)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
por: Núñez López, Concepción, et al.
Publicado: (2023)

Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
por: Núñez López, Concepción, et al.
Publicado: (2023)

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Characteristics and management of pyogenic liver abscess: A European experience
por: Serraino, Cristina, et al.
Publicado: (2018)

BNT162b2 COVID-19 Vaccine Safety among Healthcare Workers of a Tertiary Hospital in Italy
por: Beccia, Flavia, et al.
Publicado: (2023)

Effect of Previous SARS-CoV-2 Infection on Antibody Response to a Single Immunization with the Pfizer BNT162b mRNA Vaccine Among Healthcare Workers in Foggia, Italy
por: Homan, Tobias, et al.
Publicado: (2021)

Telemedicine in Italy, the starting point
por: Parretti, Chiara, et al.
Publicado: (2022)

Persistence of Anti-S Titre among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19
por: Coppeta, Luca, et al.
Publicado: (2021)

SARS-CoV-2 antibody response after BNT162b2 mRNA vaccine in healthcare workers: Nine-month of follow-up
por: Mastroianni, Franco, et al.
Publicado: (2022)

Effectiveness of BNT162b2 COVID-19 vaccine among healthcare workers of a large hospital, Milan, Italy
por: Consonni, Dario, et al.
Publicado: (2022)

Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers
por: Syrimi, Natalia, et al.
Publicado: (2023)

Loneliness that destroys and upsets: A lesson from and beyond COVID-19
por: Bracco, Christian, et al.
Publicado: (2021)

Short-Term Safety of Booster Immunization With BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
por: Paran, Yael, et al.
Publicado: (2021)

Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea
por: Lee, Yun Woo, et al.
Publicado: (2021)

Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan
por: Sanada, Takahiro, et al.
Publicado: (2023)

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
por: Bayart, Jean-Louis, et al.
Publicado: (2021)

Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2022)

Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination
por: Kurashima, Kazuyoshi, et al.
Publicado: (2022)

Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care”
por: Chirumbolo, Salvatore, et al.
Publicado: (2023)

Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
por: Zurac, Sabina, et al.
Publicado: (2022)

Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
por: Çulpan, Hazal Cansu, et al.
Publicado: (2023)

High-dose steroids for the treatment of severe COVID-19: comment
por: Tanaka, Shuichi, et al.
Publicado: (2021)

Lung ultrasound presentation of covid-19 patients: phenotypes and correlations—comment
por: Nekludova, Galina, et al.
Publicado: (2021)

Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)
por: Isgrò, Maria Antonietta, et al.
Publicado: (2022)

Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers
por: Zaffina, Salvatore, et al.
Publicado: (2021)

Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan
por: Hatakeyama, S., et al.
Publicado: (2022)

Antibody response to BNT162b2 mRNA vaccine in healthcare workers and residents in a long‐term care facility
por: Kitagawa, Takao, et al.
Publicado: (2022)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases: Comment
por: Magon, Arianna, et al.
Publicado: (2021)

Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers
por: Padoan, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dev1cmq1d5ro2i4g35jbjs4ipl